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To the Editor: Dengue virus (DENV) is a member of 
the family Flaviviridae, genus Flavivirus, and comprises 
4 serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). 
DENV is transmitted by Aedes spp. mosquitoes in subtropi-
cal and tropical countries; an estimated 390 million dengue 
infections occurred worldwide in 2010 (1). In Africa, locally 
acquired dengue cases have been reported from 22 countries 
during 1960–2010, and there is evidence of transmission in 
34 countries (2). The burden of dengue in Africa was recently 
estimated to be in the same range as that in Latin America (1).
In 2013, a 71-year-old man came to the Tropical Medi-
cine Clinic at Heidelberg University Hospital (Heidelberg, 
Germany) with suspected dengue fever 3 days after return-
ing from West Africa to Germany. The patient had traveled 
for ≈6 weeks from mid-September through mid-October 
2013 to Togo (Lomié, first 3 weeks), Benin (Ouidah, 1 
week), back to Togo (Lomié, 1 week), and Burkina Faso 
(Ouagadougou, 3 days).
Tests results for DENV nonstructural protein 1 and 
IgM against DENV were positive. The result of a real-time 
reverse transcription PCR for DENV 1–4 was also positive. 
A serotype-specific real-time reverse transcription PCR 
identified DENV-3 (3,4).
To obtain the sequence of a 1,479-nt fragment of the 
complete gene of the envelope glycoprotein gene, we de-
signed generic primers specific for all complete DENV-
3 genomes available from GenBank (alignment was 
performed by using Geneious version 6.1; http://www.
geneious.com), which were then sequentially adapted 
to sequences obtained (primers and protocol available 
upon request). Sequencing of the complete envelope 
glycoprotein gene of the virus isolated from the patient 
identified DENV-3 genotype III (GenBank accession 
no. KJ922394).
For phylogenetic comparison, we chose all DENV-3 
sequences available from Africa and neighboring regions 
and a set of global sequences that represented different gen-
otypes; DENV-1 was used an outgroup. Sequences were 
aligned on the basis of translated nucleotide sequences, and 
a neighbor-joining tree with p-distance was inferred with 
1,000 bootstrap replicates in MEGA version 5.2.1 (http://
www.megasoftware.net/) for a 1,479-nt fragment span-
ning the complete gene of the envelope glycoprotein and a 
smaller fragment of 220 nt (Figure). We observed cluster-
ing of the virus sequence with those of strains from Côte 
d’Ivoire and Benin. Genetic identity was 99% with strains 
from Côte d’Ivoire (AB447989) (1,472/1,479 nt) and Be-
nin (AB690858) (1,469/1,479nt).
Because of limited availability of only 4 complete 
envelope glycoprotein gene sequences from Africa, an 
additional phylogenetic analysis was performed with a 
smaller fragment of 220 nt to include more sequences of 
African origin. A total of 7 sequences, including additional 
sequences from Senegal and Cameroon, were available. 
Clustering of sequences of African origin was confirmed 
in this analysis; highest sequence identity of virus isolated 
from the patient was with viruses isolated in Côte d’Ivoire, 
Benin, and Senegal.
Nearly all sequence data for DENV-3 from Africa 
originate from returning travelers, such as reports of im-
ported cases in 2006 from Cameroon to Spain (5), from 
Senegal to Spain in 2007 and to Italy in 2010 (5,6), from 
Côte d’Ivoire to France and Japan in 2008 (7,8), from Be-
nin to Japan and France in 2010 (8,9), and from Eritrea to 
Finland in 2010 (5). Phylogenetic analysis of virus strains 
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Figure. Phylogenetic trees of A) a 1,479-nt fragment of the complete envelope glycoprotein gene and B) a 220-nt fragment of the partial 
envelope glycoprotein gene of dengue virus. Phylogeny was based on a neighbor-joining tree with p-distance and 1,000 bootstrap 
replicates. Bootstrap values >75 are indicated along the branches. The strain isolated in this study from a 71-year-old man who returned 
from West Africa to Germany is indicated in bold. Scale bars indicate percentage of nucleotide distance.   
identified in these cases shows clustering with sequences 
of African origin, as observed for our patient (6–8). How-
ever, because only a small number of sequences of DENV-
3 strains from Africa are available (and not all sequences 
refer to the same genomic region), a comparative phylo-
genetic analysis of strains from Africa is limited. A recent 
investigation of febrile patients from Gabon showed not 
only circulation of DENV-3, but simultaneous circulation 
of 3 DENV serotypes (DENV-1, DENV-2, and DENV-3) 
in West Africa (10).
Molecular data for travelers are useful in areas 
where DENV diagnosis and surveillance are not routine-
ly performed. The case-patient reported here highlights 
sustained transmission of DENV-3 genotype III strains 
or closely related strains during recent years. Increas-
ing numbers of reports on local outbreaks and available 
phylogenetic information support ongoing DENV-3 
transmission in West Africa. If one assumes a maximum 
incubation time of 14 days, our case-patient was most 
probably exposed to DENV in Togo or Burkina Faso. 
These 2 countries have not been considered as areas to 
which DENV is endemic. Our findings indicate that fur-
ther systematic evaluation of the risk and disease burden 
of dengue in Africa is urgently needed. Dengue fever 
should be considered in travelers returning from Africa 
with acute febrile illness.
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To the Editor: Group A streptococci (GAS) can cause 
severe invasive diseases, such as necrotizing fasciitis, strep-
tococcal toxic shock syndrome, and sepsis. In 2012, ≈11,000 
cases of invasive GAS (iGAS) disease and 1,100 associated 
deaths occurred in the United States (1,2). The risk for iGAS 
infection is 10 times higher among Native Americans than 
among the general population (3). Other predisposing fac-
tors for iGAS infection include skin wounds and underly-
ing diseases, such as diabetes (1,3,4). Household risk factors 
include exposure to children with pharyngitis and crowding 
(4). Most iGAS infections occur sporadically within the 
community. Postpartum and postsurgical clusters arising 
from a common nosocomial source occur but are rare (5).
During the winter of 2012–13, a 3-fold increase in 
necrotizing fasciitis was observed at an Arizona hospital 
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